Hormone replacement therapy and the risk of breast lesions that predispose to cancer

American Surgeon

Volumn 63, Issue 10, 1997, Pages 858-860

  Cahn, Mitchell D ^a   Tran, Than ^a   Theur, Charles P ^a   Butler, John A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST ADENOMA; BREAST CARCINOMA; BREAST HYPERPLASIA; BREAST PAPILLOMA; CANCER SUSCEPTIBILITY; FEMALE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST DISEASES; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; COCARCINOGENESIS; DISEASE SUSCEPTIBILITY; EPITHELIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; HYPERPLASIA; MAMMOGRAPHY; MIDDLE AGED; ODDS RATIO; PAPILLOMA, INTRADUCTAL; PHYSICAL EXAMINATION; POPULATION SURVEILLANCE; POSTMENOPAUSE; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES;

EID: 0030867507     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wingo P, Tong T, Bolden S. Cancer statistics, 1995. Ca Cancer J Clin 1995;45:8-30.
2. Page HS, Asire AJ. Cancer Rates and Risks. NIH Publication No. 85-691. Washington, DC: U.S. Department of Health and Human Services, 1995.
3. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
4. La Vecchia C, Negri E, Franceschi S, et al. Hormone replacement therapy and breast cancer risk: A cooperative Italian study. Br J Cancer 1995;72:244-8.
5. Hulka BS. Links between hormone replacement therapy and neoplasia. Fertil Steril 1994;62(Suppl 2):168s-75s.
6. Schairer C, Byrne C, Keyl PM, et al. Menopausal estrogen and estrogen-progestin replacement therapy and the risk of breast cancer. Cancer Causes Control. 1994;5:491-500.
7. Risch HA, Howe GR. Menopausal hormone usage and breast cancer in Saskatchewan: A record-linkage cohort study; Am J Epidemiol 1994;139:670-83.
8. Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and the risk of breast cancer: Results from epidemiologic studies. Am J Obstet Gynecol 1993;168:1473-80.
9. Sillero-Arenas M, Delgado-Rodriguez M, Rodrigues-Canterras R, et al. Menopausal hormone replacement therapy and breast cancer: A meta-analysis. Obstet Gynecol 1992;79: 286-94.
10. Helzlsouer KJ, Couzi R. Hormones and breast cancer. Cancer 1995;76(Suppl 10):2059-63.
11. Roy JA. Hormone replacement therapy in women with breast cancer: Do the risks outweigh the benefits? J Clin Oncol 1996;14:997-1006.
12. MacLennan AH, Smith M. Hormone replacement therapy and breast cancer: What are the facts? Med J Aust 1995;163: 483-5.
13. Hulka BS, Liu ET, Lininger RA. Steroid hormones and the risk of breast cancer. Cancer 1994;74(Suppl 3):1111-24.
14. Ewertz M. Epidemiology of breast cancer: The Nordic contribution. Eur J Surg 1996;162:97-9.
15. Page DL, Jensen RA. Evaluation and management of high risk and premalignant lesions of the breast. World J Surg 1994; 18:32-8.
16. Lobo RA. Benefits and risks of estrogen replacement therapy. Am J Obstet Gynecol 1995;173:982-9.
17. Lip GY. Hormone replacement and cardiovascular risk: The cardiovascular physician's viewpoint; J Intern Med 1995;238: 389-99.